Drug price transparency could return as top issue

by Tim Darnell

Drug prices and who controls them could be back before the General Assembly this winter, as consumer advocates and pharmacy benefit managers remain at odds over issues such as drug price transparen...

Exclusive Subscriber Content

Premium Content is available to subscribers only. Please login to access content or purchase a subscription.

Submit your webform

Letter to the Editor

We welcome letters to the editor online. Letters are published at the sole discretion of the newspaper staff in the order they are received.

Submitter Contact Information

Your Name

Your Email

Phone Number

Address of Residence

City/Town

State/Province

ZIP/Postal Code

Your letter to the editor (500 character limit, please paste it in):

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.